ID

13128

Descrizione

Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00983684

collegamento

https://clinicaltrials.gov/show/NCT00983684

Keywords

versioni (1)
  1. 18/01/16 18/01/16 -
Caricato su

18 gennaio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Invasive Breast Cancer NCT00983684

Inglese

Eligibility Invasive Breast Cancer NCT00983684

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 45 years or older
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
operable invasive breast cancer (t1 and small t2, n0-1, m0) confirmed by cytological or histological examination
Descrizione

breast cancer

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0010819
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0019638
UMLS CUI [2,2]
C0678222
suitable for breast conserving surgery
Descrizione

surgery

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0038894
previously diagnosed and treated contralateral breast cancer may be entered but will be randomised to a separate stratum.
Descrizione

contralateral breast cancer

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0441988
available for regular follow-up for at least ten years.
Descrizione

compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1321605
note: individual centres may wish to restrict entry to a more exactly defined subset of patients, in which case, only patients with these characteristics may be entered by that particular centre. for example, centres may decide at outset to recruit only women over 50 or even over 65 years of age. such policies must be pre-defined in writing and approved by the international steering committee.
Descrizione

ID.6

Tipo di dati

text

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than one obvious cancer in the same breast as diagnosed by clinical examination, mammography or ultrasonography.
Descrizione

multifocal carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205292
bilateral breast cancer at the time of diagnosis.
Descrizione

bilateral breast cancer

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0238767
ipsilateral breast had a previous cancer and/or irradiation.
Descrizione

irradiation previous cancer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0678222
patients known to have brca2 gene mutations, but testing for gene mutations is not required
Descrizione

brca2

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0598034
lobular cancer or extensive intraductal component (eic =>25% of the tumour is intraductal) on core biopsy or initial pathology (if performed)
Descrizione

biopsy, pathology

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005558
UMLS CUI [2]
C0030664
patients undergoing primary medical treatment (hormones or chemotherapy) as initial treatment with neoadjuvant intent of reducing tumour size should be excluded; those given short duration (up to 4 weeks) systemic therapy can be included.
Descrizione

neoadjuvant therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0600558
patients presenting with gross nodal disease, considered to be clinically malignant or proven cytologically or by scanning. in general, 4 or more positive nodes or extranodal spread are not suitable for targit alone and should receive ebrt as well. however, individual centres may decide that anything more than micrometastasis should receive ebrt.
Descrizione

lymph nodes

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0024204
patients with any severe concomitant disease that may limit their life expectancy.
Descrizione

comorbidity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0023671
previous history of malignant disease does not preclude entry if the expectation of relapse-free survival at 10 years is 90% or greater.
Descrizione

cancer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
any factor included as exclusion criterion in the local centre's treatment policy. this is particularly relevant to patients entered into the post pathology stratum.
Descrizione

additional criteria

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
no more than 30 days can have elapsed between last breast cancer surgery (not axillary) and entry into the trial for patients in the post-pathology stratification.
Descrizione

time

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0040223
Ritorna all'inizio della pagina

Similar models

Eligibility Invasive Breast Cancer NCT00983684

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age 45 years or older
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
operable invasive breast cancer (t1 and small t2, n0-1, m0) confirmed by cytological or histological examination
boolean
C0010819 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0019638 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
surgery
Item
suitable for breast conserving surgery
boolean
C0038894 (UMLS CUI [1])
contralateral breast cancer
Item
previously diagnosed and treated contralateral breast cancer may be entered but will be randomised to a separate stratum.
boolean
C0678222 (UMLS CUI [1,1])
C0441988 (UMLS CUI [1,2])
compliance
Item
available for regular follow-up for at least ten years.
boolean
C1321605 (UMLS CUI [1])
ID.6
Item
note: individual centres may wish to restrict entry to a more exactly defined subset of patients, in which case, only patients with these characteristics may be entered by that particular centre. for example, centres may decide at outset to recruit only women over 50 or even over 65 years of age. such policies must be pre-defined in writing and approved by the international steering committee.
text
Item Group
C0680251 (UMLS CUI)
multifocal carcinoma
Item
more than one obvious cancer in the same breast as diagnosed by clinical examination, mammography or ultrasonography.
boolean
C0678222 (UMLS CUI [1,1])
C0205292 (UMLS CUI [1,2])
bilateral breast cancer
Item
bilateral breast cancer at the time of diagnosis.
boolean
C0678222 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
irradiation previous cancer
Item
ipsilateral breast had a previous cancer and/or irradiation.
boolean
C1522449 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
brca2
Item
patients known to have brca2 gene mutations, but testing for gene mutations is not required
boolean
C0598034 (UMLS CUI [1])
biopsy, pathology
Item
lobular cancer or extensive intraductal component (eic =>25% of the tumour is intraductal) on core biopsy or initial pathology (if performed)
boolean
C0005558 (UMLS CUI [1])
C0030664 (UMLS CUI [2])
neoadjuvant therapy
Item
patients undergoing primary medical treatment (hormones or chemotherapy) as initial treatment with neoadjuvant intent of reducing tumour size should be excluded; those given short duration (up to 4 weeks) systemic therapy can be included.
boolean
C0600558 (UMLS CUI [1])
lymph nodes
Item
patients presenting with gross nodal disease, considered to be clinically malignant or proven cytologically or by scanning. in general, 4 or more positive nodes or extranodal spread are not suitable for targit alone and should receive ebrt as well. however, individual centres may decide that anything more than micrometastasis should receive ebrt.
boolean
C0024204 (UMLS CUI [1])
comorbidity
Item
patients with any severe concomitant disease that may limit their life expectancy.
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
cancer
Item
previous history of malignant disease does not preclude entry if the expectation of relapse-free survival at 10 years is 90% or greater.
boolean
C0006826 (UMLS CUI [1])
additional criteria
Item
any factor included as exclusion criterion in the local centre's treatment policy. this is particularly relevant to patients entered into the post pathology stratum.
boolean
C0680251 (UMLS CUI [1])
time
Item
no more than 30 days can have elapsed between last breast cancer surgery (not axillary) and entry into the trial for patients in the post-pathology stratification.
boolean
C0040223 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial